August 1997
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS70
Academic Journal
Presents an abstract of the research manuscript `Evaluation of hybrid capture HPV testing in the management of patients with ASCUS/LSIL pap smears,' by C.M. McLachlin et al.


Related Articles

  • HPV Testing in the Evaluation of the Minimally Abnormal Papanicolaou Smear. Apgar, Barbara S. // American Family Physician;5/15/1999, Vol. 59 Issue 10, p2794 

    Discusses the use of human papillomavirus (HPV) testing in the evaluation of the minimally abnormal Papanicolaou (Pap) smear. Role of high- and low-risk HPV types; Concept of HPV testing; Management of the minimally abnormal Pap smear.

  • Pap Plus HPV Screens Save Lives.  // Medical Update;May2002, Vol. 27 Issue 11, p7 

    Provides information on the health benefits from regular Pap smears with human papillomavirus screening.

  • Papanicolaou tests and molecular analyses using new fluid-based specimen collection technology in 3000 Japanese women. Masumoto, N; Fujii, T; Ishikawa, M; Mukai, M; Saito, M; Iwata, T; Fukuchi, T; Kubushiro, K; Tsukazaki, K; Nozawa, S // British Journal of Cancer;6/16/2003, Vol. 88 Issue 12, p1883 

    A fluid-based Papanicolaou test has been established to improve sample collection and preparation. This study was the first large-scale investigation in Japan to examine the feasibility of using fluid-based Papanicolaou specimens to detect human papillomavirus (HPV) using Hybrid Capture II and...

  • Filling a Pap gap. B.A. // Advocate;3/5/2002, Issue 858, p18 

    Reports the importance of PAP test to detect abnormalities in American women. Recommendation for women to undergo human papillomavirus test to determine the presence of cervical cancer; Rate of cervical cancer cases caused by human papillomavirus; Benefits of the HPV test.

  • HPV DNA test.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1095 

    A definition of the medical term "HPV DNA test," which refers to a test to determine whether cancer-causing variant of human papillomavirus are present in the endo- or ectocervix of patients undergoing Papanicolaou (PAP) testing, is presented.

  • Get ready for changes in HPV DNA testing.  // Contraceptive Technology Update;Jun2009, Vol. 30 Issue 6, p67 

    The Food and Drug Administration has approved two new tests for human papillomavirus (HPV): the Cervista HPV 16/18 test, which detects the DNA sequences for HPV types 16 and 18 in cervical cells, and the Cervista HPV HR test, which detects essentially all of the high-risk HPV types in cervical...

  • A case of HPV-53-related cervical cancer in an elderly patient. Lieveld, Marusya; Padalko, Elizaveta; Praet, Marleen; Vanden Broeck, Davy // Clinical Interventions in Aging;2014, Vol. 9, p1933 

    A letter to the editor is presented in response to a case report involving a 79-year-old women patient diagnosed with human papillomavirus (HPV) invasive cervical cancer and had a history of normal Pap smears.

  • The HPV DNA virus hybrid capture assay: What is it--and where do we go from here. Vernick, John P.; Steigman, Carmen K. // MLO: Medical Laboratory Observer;Mar2003, Vol. 35 Issue 3, p8 

    Examines the role of Pap smears and human papillomavirus (HPV) DNA testing in cervical cancer diagnosis. Reduction in the mortality of patient with cervical cancer by PAP test; Indications of HPV DNA testing; Detection of cytological abnormalities in cervix uteri. INSET: CE CONTINUING EDUCATION.

  • The cervical cancer test you should ask for.  // Glamour;Aug2002, Vol. 100 Issue 8, p86 

    Presents guidelines for cervical cancer test in the U.S. Implications of a pap smear result of atypical squamous cells of undetermined significance; Significance of the human papillomavirus test for preventing cancer; Cancer prevention guidelines sponsored by the American Society for Colposcopy...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics